^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CD70 CAR-T
i
Other names: CD70 CAR-T, CD70-targeted CAR-T
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Chongqing Precision Biotech
Drug class:
CD70-targeted CAR-T immunotherapy
Related drugs:
17d
Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE (clinicaltrials.gov)
P1, N=18, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial
|
CD70 CAR-T
4ms
Clinical Study of BCMA/CD70-targeted CAR-T Therapy for Refractory Pediatric Rheumatic Diseases (clinicaltrials.gov)
P1, N=11, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial
|
CD70 (CD70 Molecule)
|
CD70 CAR-T
4ms
Safety and Efficacy of CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors: A Clinical Trial (clinicaltrials.gov)
P1, N=90, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial
|
CD70 (CD70 Molecule)
|
cyclophosphamide • fludarabine IV • CD70 CAR-T
8ms
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
P1, N=30, Recruiting, Weijia Fang, MD | Trial completion date: May 2025 --> May 2027 | Trial primary completion date: May 2024 --> May 2026
Trial completion date • Trial primary completion date
|
CD70 (CD70 Molecule)
|
cyclophosphamide • fludarabine IV • CD70 CAR-T
9ms
Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE (clinicaltrials.gov)
P1, N=18, Recruiting, The Children's Hospital of Zhejiang University School of Medicine
New P1 trial
|
CD70 (CD70 Molecule)
|
CD70 CAR-T
2years
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer (clinicaltrials.gov)
P1, N=36, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial • Metastases
|
CD70 (CD70 Molecule)
|
cyclophosphamide • CD70 CAR-T
over2years
A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
P1, N=48, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial • Metastases
|
IL6 (Interleukin 6) • CD70 (CD70 Molecule)
|
CD70 expression
|
cyclophosphamide • CD70 CAR-T
over3years
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
P1, N=36, Recruiting, Weijia Fang, MD
New P1 trial
|
IL6 (Interleukin 6) • CD70 (CD70 Molecule)
|
CD70 expression
|
cyclophosphamide • CD70 CAR-T
over3years
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T (clinicaltrials.gov)
P1, N=48, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial
|
IL6 (Interleukin 6) • CD70 (CD70 Molecule)
|
CD70 expression
|
cyclophosphamide • CD70 CAR-T
over3years
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors (clinicaltrials.gov)
P1, N=36, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial
|
IL6 (Interleukin 6) • CD70 (CD70 Molecule)
|
CD70 expression
|
cyclophosphamide • CD70 CAR-T
over3years
A Clinical Study of CD70-targeted CAR-T in the Treatment of Advanced/Metastatic Renal Cell Carcinoma (clinicaltrials.gov)
P1, N=24, Recruiting, Chongqing Precision Biotech Co., Ltd
New P1 trial
|
IL6 (Interleukin 6) • CD70 (CD70 Molecule)
|
CD70 expression
|
cyclophosphamide • CD70 CAR-T
Share via
